Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May;37(5):723-725.
doi: 10.1111/dme.14300. Epub 2020 Apr 3.

COVID-19 and diabetes

R C W Ma  1   2 , R I G Holt  3   4
Affiliations
Editorial

COVID-19 and diabetes

R C W Ma et al. Diabet Med. 2020 May.
No abstract available

PubMed Disclaimer

Figures

None
Credit: NIAID‐RML / NATIONAL INSTITUTES OF HEALTH / SCIENCE PHOTO LIBRARY Caption: COVID‐19 coronavirus particles, coloured transmission electron micrograph (tEM). Also called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), this virus causes the disease COVID‐19. This sample was isolated from a patient in the USA. SARS‐CoV‐2 was first identified in Wuhan, China, in December 2019. It is an enveloped RNA (ribonucleic acid) virus. The coronaviruses take their name from their crown (corona) of surface proteins, which are used to attach and penetrate their host cells. As of mid‐March 2020, over 230,000 people have been infected with over 9,500 deaths.
See this image and copyright information in PMC

Comment on

References

    1. Baud D, Qi X, Nielsen‐Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID‐19 infection. Lancet Infect Dis 2020; 10.1016/S1473-3099(20)30195-X. Epub 12 March 2020. - DOI - PMC - PubMed
    1. Wu H, Lau ESH, Ma RCW, Kong APS, Wild SH, Goggins W et al. Secular trends in all‐cause and cause‐specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study. Diabetologia 2020; 63: 757–766. - PubMed
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 10.1056/NEJMoa2002032. Epub 28 February 2020. - DOI - PMC - PubMed
    1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395 (10024): 565–574. - PMC - PubMed
    1. Hoffman M, Kleine‐Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al. SARS‐CoV‐2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020: 10.1016/j.cell.2020.02.0524. Epub 4 March 2020. - DOI - PMC - PubMed